Shared from southampton.ac.uk.
New research by the University of Southampton has revealed how a commonly prescribed Parkinson’s disease drug disrupts the gut microbiome, potentially causing health complications.
The Southampton scientists, working with colleagues at the universities of Vienna, Boston and Aalborg, have shown the drug ‘entacapone’, and possibly other similar medications, starve important microbes living in the gut of a source of iron which helps them to function normally.
The study, published in Nature Microbiology , explores the often-overlooked impact of human-targeted drugs on the microbial communities that play a critical role in human health.
